Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-24T04:32:19.819Z Has data issue: false hasContentIssue false
  • English
  • Français

Are personalised treatments of adult depression finally within reach?

Published online by Cambridge University Press:  11 March 2016

P. Cuijpers  and
H. Christensen
P. Cuijpers*
Affiliation:
Department of Clinical, Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, The Netherlands EMGO Institute for Health and Care Research, The Netherlands
H. Christensen
Affiliation:
Black Dog Institute, University of New South Wales, Randwick, NSW, Australia
*
*Address for correspondence: P. Cuijpers, Professor of Clinical Psychology, Department of Clinical Psychology, Vrije Universiteit Amsterdam, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Antidepressantsdepressionmood disorders unipolarpsychotherapy
Type
Commentary to Special Article
Information
Epidemiology and Psychiatric Sciences , Volume 26 , Issue 1 , February 2017 , pp. 40 - 42
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andrews, G, Issakidis, C, Sanderson, K, Corry, J, Lapsley, H (2004). Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. British Journal of Psychiatry 184, 526–533.CrossRefGoogle ScholarPubMed
Baumeister, H, Gordon, P (2012). Meta-review of depressive subtyping models. Journal of Affective Disorders 139, 126–140.Google Scholar
Cuijpers, P (2014). Personalized treatment for functional outcome in depression. Medicographia 36, 476–481.Google Scholar
Cuijpers, P, Reynolds, CF III, Donker, T, Li, J, Andersson, G, Beekman, A (2012). Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review. Depression and Anxiety 29, 855–864.CrossRefGoogle ScholarPubMed
DeRubeis, RJ, Cohen, ZD, Forand, NR, Fournier, JC, Gelfand, LA, Lorenzo-Luaces, L (2014). The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS ONE 9, e83875.Google Scholar
Holsboer, F (2008). How can we realize the promise of personalized antidepressant medicines? Nature Reviews Neuroscience 9, 638–646.Google Scholar
Kessler, RC, Van Loo, H, Wardenaar, KJ, Bossarte, R, Ebert, DD, De Jong, PJ, Nierenberg, AA, Rosellini, A, Sampson, N, Schoevers, RA, Wilcox, M, Zaslavsky, A (2016). Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiology and Psychiatric Sciences. doi:10.1017/S2045796016000020.Google Scholar
Kraemer, HC (2013). Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Statistics in Medicine 32, 1964–1973.CrossRefGoogle ScholarPubMed
van Loo, HM, de Jonge, P, Romeijn, J-W, Kessler, RC, Schoevers, RA (2012). Data-driven subtypes of major depressive disorder: a systematic review. BMC Medicine 10, 156.Google Scholar